A detailed history of Msh Capital Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Msh Capital Advisors LLC holds 34,100 shares of PFE stock, worth $870,573. This represents 0.28% of its overall portfolio holdings.

Number of Shares
34,100
Previous 54,253 37.15%
Holding current value
$870,573
Previous $2.84 Billion 68.2%
% of portfolio
0.28%
Previous 1.32%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$24.8 - $30.19 $499,794 - $608,419
-20,153 Reduced 37.15%
34,100 $905 Million
Q3 2024

Feb 13, 2025

SELL
$27.7 - $31.39 $8,476 - $9,605
-306 Reduced 0.46%
66,498 $1.92 Billion
Q2 2024

Feb 13, 2025

BUY
$25.26 - $29.6 $48,524 - $56,861
1,921 Added 2.96%
66,804 $1.87 Billion
Q1 2024

Feb 13, 2025

SELL
$25.89 - $29.73 $10,951 - $12,575
-423 Reduced 0.65%
64,883 $1.8 Billion
Q4 2023

Feb 13, 2025

SELL
$26.13 - $33.94 $118,499 - $153,917
-4,535 Reduced 6.49%
65,306 $1.88 Billion
Q3 2023

Feb 13, 2025

BUY
$32.09 - $37.51 $183,041 - $213,957
5,704 Added 8.89%
69,841 $2.32 Billion
Q2 2023

Feb 13, 2025

BUY
$36.12 - $41.79 $300,735 - $347,943
8,326 Added 14.92%
64,137 $2.35 Billion
Q1 2023

Feb 13, 2025

BUY
$39.39 - $51.28 $22,924 - $29,844
582 Added 1.05%
55,811 $2.28 Billion
Q4 2022

Feb 13, 2025

BUY
$41.75 - $54.5 $42,000 - $54,827
1,006 Added 1.86%
55,229 $2.83 Billion
Q3 2022

Feb 13, 2025

BUY
$43.76 - $53.42 $880,582 - $1.07 Million
20,123 Added 59.01%
54,223 $2.37 Billion
Q2 2022

Feb 13, 2025

BUY
$46.53 - $55.17 $29,127 - $34,536
626 Added 1.17%
54,253 $2.84 Billion
Q1 2022

Feb 13, 2025

BUY
$45.75 - $56.69 $164,471 - $203,800
3,595 Added 7.19%
53,627 $2.78 Billion
Q4 2021

Feb 13, 2025

BUY
$41.32 - $61.25 $2.07 Million - $3.06 Million
50,032 New
50,032 $2.95 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $143B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Msh Capital Advisors LLC Portfolio

Follow Msh Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Msh Capital Advisors LLC with notifications on news.